NeuroOne Medical Technologies (Nasdaq:NMTC) today announced the first clinical case performed with its Evo sEEG in robotic neurosurgery. Dr. William Bingaman performed the procedure with the electrode — exclusively marketed by Zimmer Biomet — at Cleveland Clinic. It marks the first procedure to utilize NeuroOne’s Evo sEEG with Zimmer Biomet’s Rosa One Brain. The Rosa […]
neuroone
NeuroOne launches Evo sEEG electrodes in the U.S.
NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that it commercially launched its Evo sEEG electrode line in the U.S. Zimmer Biomet holds exclusive worldwide distribution rights to the Evo Cortical and sEEG product lines. NeuroOne expects the line to utilize Zimmer Biomet’s Rosa One Brain robotic surgery platform for neurosurgical procedures. Zimmer paid $3.5 million to […]
NeuroOne completes animal implant of thin film lead for spinal cord stimulation
NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that it completed an initial animal implant of its novel thin film paddle leads. These leads enable spinal cord stimulation (SCS). NeuroOne intends for the devices to treat patients with chronic back pain due to multiple failed back surgery syndrome, intractable low back pain and leg pain. Eden Prairie, […]
NeuroOne completes feasibility study of OneRF ablation system
NeuroOne Medical today announced it completed a feasibility study of its OneRF ablation system. The feasibility study evaluated the OneRF ablation system that uses existing sEEG diagnostic electrodes for brain tissue lesioning. Researchers completed the study in an animal model. The research combined the sEEG electrodes with a proprietary RF generator. In addition, there was […]
NeuroOne begins shipping 30-day sEEG electrodes to Zimmer Biomet
NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that shipped its first commercial order in an agreement with Zimmer Biomet (NYSE:ZBH). Zimmer Biomet holds an exclusive development and distribution agreement with NeuroOne for its thin film technology. It already sells NeuroOne’s earlier cortical strip and grid electrode devices. Over a year ago, Zimmer Biomet placed initial stocking […]
FDA clears NeuroOne’s Evo sEEG electrode for 30-day use
NeuroOne today announced it received expanded FDA 510(k) clearance to market its Evo sEEG Electrode technology for temporary use with brain recording, monitoring and stimulation equipment. Eden Prairie, Minnesota-based NeuroOne previously announced it resubmitted its 510(k) application for up to 30-day use. The resubmission included additional biocompatibility testing as requested by the FDA. The new […]
NeuroOne submits special FDA 510(k) application for Evo sEEG electrode
NeuroOne (Nasdaq:NMTC) announced today that it submitted a special FDA 510(k) application for its sEEG electrode. Eden Prairie, Minnesota-based NeuroOne’s special submission aims to extend the duration of use for its Evo sEEG electrode from less than 24 hours to less than 30-day use. The company said in a news release that, according to FDA […]
Zimmer Biomet speeds up investments in NeuroOne
NeuroOne Medical Technologies (Nasdaq: NMTC) announced today that it will receive an accelerated $3.5 million milestone payment from Zimmer Biomet. The milestone payment is related to Eden Prairie, Minnesota–based NeuroOne’s Evo sEEG electrode technology, which last year received FDA 510(k) clearance for temporary (less than 24 hours) recording, monitoring and stimulation of electrical signals at […]
NeuroOne announces first clinical case using Evo sEEG electrodes
NeuroOne Medical Technologies today announced the first clinical case using its Evo sEEG electrodes. The procedure was performed at Emory University by Dr. Robert Gross for intraoperative brain mapping at the subsurface level of the brain, according to the Eden Prairie, Minnesota-based company. “This first clinical case use represents a major milestone achievement of one […]
FDA clears NeuroOne’s Evo sEEG electrode
NeuroOne Medical Technologies (NMTC) announced that it received FDA 510(k) clearance for its Evo sEEG electrode technology. Eden Prairie, Minnesota-based NeuroOne’s Evo sEEG electrode technology received clearance for temporary (less than 24 hours) recording, monitoring and stimulation of electrical signals at the subsurface level of the brain, according to a news release. The Evo sEEG […]
NeuroOne gains Nasdaq listing
NeuroOne Medical Technologies (OTC:NMTC) announced that it was approved to uplist and begin trading on the Nasdaq market. Eden Prairie, Minn.-based NeuroOne expects trading to commence today at the open of the market, with the company trading under the “NMTC” ticker, according to a news release. The developer of surgical care options for patients suffering […]
